These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1245938)
1. Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine. Marine WM; Stuart-Harris C J Pediatr; 1976 Jan; 88(1):26-30. PubMed ID: 1245938 [TBL] [Abstract][Full Text] [Related]
2. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Wright PF; Sell SH; Thompson J; Karzon DT J Pediatr; 1976 Jan; 88(1):31-5. PubMed ID: 1245939 [TBL] [Abstract][Full Text] [Related]
4. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults. Bernstein DI; Cherry JD Am J Dis Child; 1983 Jul; 137(7):622-6. PubMed ID: 6858973 [TBL] [Abstract][Full Text] [Related]
5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
6. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886 [TBL] [Abstract][Full Text] [Related]
7. Reactions and serologic responses after administration of inactivated monovalent influenza A/swine virus vaccines. I. Immunization of children and adults with influenza A/Shope virus vaccines. Welty PB; Epstein B; O'Brien J; Brackett RG; Brandon FB; Shillis JL J Infect Dis; 1977 Dec; 136 Suppl():S604-8. PubMed ID: 606780 [TBL] [Abstract][Full Text] [Related]
8. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. Wright PF; Cherry JD; Foy HM; Glezen WP; Hall CB; McIntosh K; Monto AS; Parrott RH; Portnoy B; Taber LH Rev Infect Dis; 1983; 5(4):758-64. PubMed ID: 6353530 [TBL] [Abstract][Full Text] [Related]
9. Systemic reactions to influenza B vaccine. Gwaltney JM; DeSanctis AN; Metzgar DP; Hendley JO Am J Epidemiol; 1977 Mar; 105(3):252-60. PubMed ID: 322477 [TBL] [Abstract][Full Text] [Related]
10. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N; Laufer J J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [TBL] [Abstract][Full Text] [Related]
18. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults. Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967 [TBL] [Abstract][Full Text] [Related]
19. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421 [TBL] [Abstract][Full Text] [Related]
20. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]